相似文献
1
Response evaluation after stereotactic ablative radiotherapy for localised non-small-cell lung cancer: an equipoise of available resource and accuracy.
Br J Radiol. 2020 Feb 1;93(1106):20190647. doi: 10.1259/bjr.20190647. Epub 2019 Dec 11.
2
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid F-fluorodeoxyglucose-positron emission tomography and CT perfusion study.
J Med Imaging Radiat Oncol. 2019 Feb;63(1):94-101. doi: 10.1111/1754-9485.12807. Epub 2018 Oct 3.
3
Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.
Cancer Treat Rev. 2016 Nov;50:240-246. doi: 10.1016/j.ctrv.2016.10.002. Epub 2016 Oct 13.
4
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Radiat Oncol. 2017 Jan 27;12(1):30. doi: 10.1186/s13014-017-0770-7.
5
Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
Eur J Cardiothorac Surg. 2016 Jun;49(6):1599-606. doi: 10.1093/ejcts/ezv421. Epub 2016 Jan 21.
6
A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.
Br J Radiol. 2017 Mar;90(1071):20160732. doi: 10.1259/bjr.20160732. Epub 2017 Feb 17.
7
Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy.
Curr Oncol. 2019 Feb;26(1):e57-e63. doi: 10.3747/co.26.4167. Epub 2019 Feb 1.
8
Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea.
Cancer Res Treat. 2017 Jul;49(3):688-694. doi: 10.4143/crt.2016.219. Epub 2016 Oct 31.
9
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.
10
Stereotactic ablative radiotherapy after concomitant chemoradiotherapy in non-small cell lung cancer: A TITE-CRM phase 1 trial.
Radiother Oncol. 2018 May;127(2):239-245. doi: 10.1016/j.radonc.2018.03.024. Epub 2018 Apr 9.
本文引用的文献
1
Core elements of national cancer control plans: a tool to support plan development and review.
Lancet Oncol. 2019 Nov;20(11):e645-e652. doi: 10.1016/S1470-2045(19)30404-8.
2
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non-Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution.
J Glob Oncol. 2018 Jul;4:1-8. doi: 10.1200/JGO.18.00020.
5
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.
JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.
6
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.
JAMA Oncol. 2018 Sep 1;4(9):1287-1288. doi: 10.1001/jamaoncol.2018.1258.
7
Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.
Pract Radiat Oncol. 2018 Mar-Apr;8(2):e71-e78. doi: 10.1016/j.prro.2017.10.008. Epub 2017 Dec 30.
8
Delivery of Global Cancer Care: An International Study of Medical Oncology Workload.
J Glob Oncol. 2018 Sep;4(4):1-11. doi: 10.1200/JGO.17.00126. Epub 2017 Dec 15.
9
The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Cancer Treat Rev. 2016 Jan;42:56-72. doi: 10.1016/j.ctrv.2015.11.007. Epub 2015 Nov 24.
10
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.
Ann Thorac Surg. 2015 Jan;99(1):270-6. doi: 10.1016/j.athoracsur.2014.08.033. Epub 2014 Nov 18.
Zotero 插件